跳至主要内容
临床试验/NCT02708056
NCT02708056已完成4 期

Sugammadex Given for the Reversal of Deep Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants: A Retrospective Study

Baskent University0 个研究点目标入组 26 人开始时间: 2015年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
26
主要终点
The efficacy of sugammadex were assessed by using Train of four (TOF)

研究概览

简要总结

The objective of this study is to evaluate the efficacy and safety of sugammadex in reversing profound neuromuscular block induced by rocuronium in infant patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 1-12 month,
  • ASA physical status 1-3 who underwent elective brain cancer surgery during general anesthesia were included in the study

排除标准

  • younger than 1month or older than 12 months.
  • hepatic or renal failure
  • A history of allergy to study medication

研究组 & 干预措施

Sugammadex, Bridion

Other

Drug were given intravenously by a anesthesiologist at the end of surgery

干预措施: Sugammadex (Drug)

结局指标

主要结局

The efficacy of sugammadex were assessed by using Train of four (TOF)

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ozlem Ozmete

Medical Doctor

Baskent University

相似试验